Tags

Type your tag names separated by a space and hit enter

Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium.
Am J Trop Med Hyg. 2015 Nov; 93(5):1110-1116.AJ

Abstract

An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

26304922

Citation

Schwartz, Brian S., et al. "Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care From the U.S. Global TravEpiNet Consortium." The American Journal of Tropical Medicine and Hygiene, vol. 93, no. 5, 2015, pp. 1110-1116.
Schwartz BS, Rosen J, Han PV, et al. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015;93(5):1110-1116.
Schwartz, B. S., Rosen, J., Han, P. V., Hynes, N. A., Hagmann, S. H., Rao, S. R., Jentes, E. S., Ryan, E. T., LaRocque, R. C., & The Global TravEpiNet Consortium, . (2015). Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. The American Journal of Tropical Medicine and Hygiene, 93(5), 1110-1116. https://doi.org/10.4269/ajtmh.15-0185
Schwartz BS, et al. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care From the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015;93(5):1110-1116. PubMed PMID: 26304922.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. AU - Schwartz,Brian S, AU - Rosen,Jessica, AU - Han,Pauline V, AU - Hynes,Noreen A, AU - Hagmann,Stefan H, AU - Rao,Sowmya R, AU - Jentes,Emily S, AU - Ryan,Edward T, AU - LaRocque,Regina C, AU - The Global TravEpiNet Consortium,, Y1 - 2015/08/24/ PY - 2015/03/08/received PY - 2015/06/28/accepted PY - 2015/8/26/entrez PY - 2015/8/26/pubmed PY - 2016/4/9/medline SP - 1110 EP - 1116 JF - The American journal of tropical medicine and hygiene JO - Am. J. Trop. Med. Hyg. VL - 93 IS - 5 N2 - An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful. SN - 1476-1645 UR - https://www.unboundmedicine.com/medline/citation/26304922/full_citation L2 - http://www.ajtmh.org/content/journals/10.4269/ajtmh.15-0185?crawler=true&mimetype=application/pdf DB - PRIME DP - Unbound Medicine ER -